Browsing by Author Shapiro, Jeremy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)Citation
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Pavlakis, Nick; Simes, Robert John; Blondal, J; Burkes, R L; Gibbs, Peter; Jonker, D; Karapetis, Christos; Lee, U; Meharchand, J; Moore, Malcolm; O'Callaghan, Chris; Price, T.J.; Rubin, S; Shapiro, Jeremy; Tebbutt, Niall C; Tu, Dongsheng; van Hazel, Guy; Vickers, M; Zalcberg, John; Zhu, L; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreAssociation of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17, Annals of Oncology, vol.24, 4, 2013,pp 953-960
2013Current opinion on optimal treatment for colorectal cancerPavlakis, Nick; Ackland, Stephen P.; Burge, Matthew; Cunningham, David; Haller, Daniel; Karapetis, Christos; Price, Timothy; Segelov, Eva; Shapiro, Jeremy; Sobrero, Alberto; Tebbutt, Niall C; Northern Clinical School: MedicineCurrent opinion on optimal treatment for colorectal cancer, Expert Review of Anticancer Therapy, vol.13, 5, 2013,pp 597-611
2015Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabGebski, Val; Price, Timothy; Sjoquist, Katrin; et al, Various; Field, Kathryn; Gibbs, Peter; McKendrick, J; Nott, Louise M; Roohullah, Aflah; Shapiro, Jeremy; Tran, Ben; Wong, Hui-Li; Yip, Desmond; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab, World Journal of Gastroenterology, vol.21, 17, 2015,pp 5352-5358
2012The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerBrown, Christopher; Gebski, Val; Horvath, Lisa; Hruby, George; Ackland, Stephen P.; Borg, M; Carroll, Susan; Cummins, Michelle M; et al, Various; Goldstein, David; Selva-Nayagam, Sid; Shapiro, Jeremy; Spry, Nigel.A.; van Hazel, Guy; Wratten, C.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: MedicineThe GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer, British Journal of Cancer, vol.106, 1, 2012,pp 61-69
2009Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.Pavlakis, Nick; Au, Heather-Jane; et al, various; Jefford, Michael; Karapetis, Christos; Kennecke, Hagen; Koski, Sherryl; Moore, M J; O'Callaghan, Chris; Shapiro, Jeremy; Tu, Dongsheng; Zalcberg, John; Northern Clinical School: MedicineHealth-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial., Journal of Clinical Oncology, vol.27, 11,pp 1822-1828
2012Management of advanced gastric cancerPavlakis, Nick; Price, Timothy; Segelov, Eva; Tebbutt, Niall; Kang, Yoon-Koo; Karapetis, Christos; Shah, Manish; Shapiro, Jeremy; Van Cutsem, E; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreManagement of advanced gastric cancer, Expert Review of Gastroenterology and Hepatology, vol.6, 2, 2012,pp 199-209
2013Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 TrialSimes, Robert John; Zalcberg, John; Charpentier, Danielle; Couture, Felix; et al, Various; Jonker, Derek J.; Karapetis, Christos (Chris); Moore, Malcolm; Nott, Louise M; Price, Timothy; Shapiro, Jeremy; Siddiqui, Jehan; Siu, Lillian L; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePhase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial, Journal of Clinical Oncology, vol.31, 19, 2013,pp 2477-2484
2005A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.Smith, D; Yip, Desmond; Bailey, W.; Dowling, R.; Gibbs, Peter; Liechtenstein, M.; Lim, L.; Little, A.; Shapiro, Jeremy; Canberra Clinical School; MedicineA prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy., BMC Cancer, vol.5,(N/A),2005,pp 132-N/A
2005Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies.Smith, D; Yip, Desmond; Bailey, W.; Dowling, R.; Gibbs, Peter; Liechtenstein, M.; Lim, L.; Little, A.; Shapiro, Jeremy; Canberra Clinical School; MedicineProspective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies., Internal Medicine Journal (Print), vol.35,(4),2005,pp 222-227
2014Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialEl-Tahche, Fabyolla; Shannon, Jenny; Alcindor, Thierry; Au, Heather-Jane; Easaw, Jay C; et al, Various; Jeffery, Mark; Jonker, Derek J.; Kotb, Rami; Moore, Malcolm; Ng, Siobhan; Ringash, Jolie; Sabesan, Sabe; Salim, Muhammad; Shapiro, Jeremy; Siu, Lillian L; Strickland, A. H.; Zalcberg, John; Central Clinical School: Medicine; Nepean Clinical School: MedicineQuality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial, Cancer, vol.120, 2, 2014,pp 181-189
2016Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015Gibbs, Peter; Thavaneswaran, Subotheni; Arnold, Dirk; Burge, Matthew; Haller, Daniel; Karapetis, Christos; Pavlakis, Nick; Price, Timothy; Punt, Cornelis JA; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreUpdate on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015, Expert Review of Anticancer Therapy, vol.16, 5, 2016,pp 557-571